Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$4.70 USD
+0.16 (3.52%)
Updated Apr 22, 2024 11:48 AM ET
After-Market: $4.98 +0.28 (5.96%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.89 | 0.00% |
Earnings Summary
For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$1.19 per share, beating the Zacks Consensus Estimate of $-1.23 per share. This reflects a positive earnings surprise of 3.25%. Look out for SYRS's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.89 per share, reflecting a year-over-year decrease of 4.71%.
Earnings History
Price & Consensus
Zacks News for SYRS
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
SYRS: What are Zacks experts saying now?
Zacks Private Portfolio Services